• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Vance defends renewed U.S. nuclear weapons tests

admin - Latest News - October 30, 2025
admin
19 views 19 secs 0 Comments



Vice President JD Vance says testing nuclear weapons is an “important part of American national security” following President Trump’s order for the Pentagon to begin testing “immediately” for the first time in decades.



Source link

TAGS:
PREVIOUS
Dr. Phil ordered to liquidate media company
NEXT
Author Jodi Picoult pushes back after Indiana high school cancels musical based on her book
Related Post
November 4, 2025
New York City GOP candidate Curtis Sliwa criticizes opponents' ties to billionaires
November 27, 2025
Nov. 27, 2025, 12:32 AM ESTBy Phil Helsel and Jennifer JettPresident Donald Trump called for a “re-examination” of all Afghan nationals who came to the U.S. during the Biden administration, hours after an Afghan man was named as the suspect in the shooting of two National Guard members in Washington, D.C.Homeland Security Secretary Kristi Noem said on X that the suspect came to the U.S. in September 2021 under Operation Allies Welcome, a Biden-era program designed to help Afghans who assisted U.S. forces and were facing a Taliban takeover.“We must now re-examine every single alien who has entered our country from Afghanistan under Biden,” Trump said in an address Wednesday night in which he called the shooting an “act of terror.”Shortly after his remarks, U.S. Citizenship and Immigration Services said it was halting the processing of immigration from Afghanistan to the U.S.“Effective immediately, processing of all immigration requests relating to Afghan nationals is stopped indefinitely pending further review of security and vetting protocols,” the agency, known as USCIS, said on X.The two National Guard members, who are from West Virginia and deployed to Washington, were shot by a gunman around 2:15 p.m. They were in critical condition Wednesday, officials said. The suspect was also shot — by whom was still under investigation — and was hospitalized, according to police.Authorities have not detailed a motive, if one is known, but D.C. Mayor Muriel Bowser said that “this is a targeted shooting” and that the suspect appeared to target the guard members.The suspect has been identified as Rahmanullah Lakanwal, 29, of Bellingham, Washington, four senior law enforcement officials briefed on the investigation told NBC News.A relative of Lakanwal’s told NBC News on Wednesday that Lakanwal arrived in the U.S. in September 2021 after having served in the Afghan Army for 10 years, alongside U.S. Special Forces.Lakanwal was stationed at a base in Kandahar for part of that time, the relative said. He came to the U.S. after the Taliban returned to power following the August 2021 withdrawal of U.S.-led forces and eventually settled in Washington state.“We were the ones that were targeted by the Taliban in Afghanistan,” the relative said. “I cannot believe it that he might do this.”A source familiar with the case and a separate law enforcement source told NBC News that the suspect was granted asylum this year.Details of what a re-examination of Afghans already in the U.S. would look like, and who arrived during the Biden administration, were not immediately clear Wednesday night.A Trump administration memo on Friday, seen by NBC News on Tuesday, called for a review of all refugees admitted to the U.S. during the Biden administration — which could affect 200,000 people.The memo calls for a “comprehensive review and a re-interview of all refugees admitted from January 20, 2021, to February 20, 2025,” including U.S. green card holders. It cites a finding by USCIS that the Biden administration “potentially prioritized expediency, quantity, and admissions over quality interviews and detailed screening and vetting.”The San Diego-based Afghan advocacy group #AfghanEvac, which works to ensure that Afghans who helped the U.S. are not abandoned in the wake of the Taliban takeover, said Wednesday’s shooting should not be used to punish Afghans in the U.S.“Afghan immigrants and wartime allies who resettle in the United States undergo some of the most extensive security vetting of any population entering the country,” Shawn VanDiver, the group’s president, said in a statement.“This individual’s isolated and violent act should not be used as an excuse to define or diminish an entire community,” he added.The Department of Homeland Security resettled more than 80,000 Afghan refugees to the U.S. before or immediately after the U.S. withdrawal from Afghanistan and the subsequent takeover by the Taliban. But many others who wanted to leave were left behind.The State Department’s inspector general’s office said in a June 2023 report that as of March of that year, 152,091 Afghan “Special Immigrant Visa” applicants in Afghanistan were waiting on processing. The visa is for Afghans who were employed by or on behalf of the U.S.Afghan immigrants and refugees, including those who aided the American military during 20 years of war, have been all but barred from entering the U.S. during Trump’s second term.On his first day in office, Trump signed an executive order suspending all refugee resettlement in the U.S. until admissions align “with the interests of the United States.” Thousands of Afghan refugees, including many who had already been approved for U.S. resettlement, are stranded in Afghanistan, Pakistan and other countries, and in some cases they have been forcibly repatriated.The Trump administration has also terminated protections that allowed Afghans to live and work in the U.S. temporarily because of dangerous conditions at home. The White House says the protections are no longer needed because it is now safe to return to Afghanistan, which is experiencing multiple humanitarian crises and which Trump described as a “hellhole” in Wednesday’s address.Advocates say that Afghans who worked with the U.S. are at risk of persecution, torture or death if they return to Taliban-ruled Afghanistan and that they undergo extensive vetting before they arrive in the U.S.Trump has said he is committed to helping Afghans who worked with the U.S. military, saying in August that “we know the good ones and we know the ones that maybe aren’t so good.”Phil HelselPhil Helsel is a reporter for NBC News.Jennifer JettJennifer Jett is the Asia Digital Editor for NBC News, based in Hong Kong.Courtney Kube, Rich Schapiro, Abigail Williams, Laura Strickler and Tom Winter contributed.
November 16, 2025
Here's the biggest news you missed this weekend
November 16, 2025
Savewith a NBCUniversal ProfileCreate your free profile or log in to save this articleNov. 16, 2025, 7:56 AM ESTBy Lindsey LeakeDo you know what your hormone levels are? Should you?Your body is home to more than 50 hormones — chemical messengers that compose the endocrine system — and hormonal changes may reflect any number of medical conditions. For example, low levels of the pancreatic hormone insulin may indicate diabetes, while high levels of the stress hormone cortisol can play a role in obesity.But some hormones such as melatonin, which is important for sleep, naturally fluctuate throughout the day. Other hormonal changes are normal at different phases of life, such as a woman’s drop in the reproductive hormones estrogen and progesterone preceding menopause.Hormones are having a moment.The Food and Drug Administration announced Nov. 10 it was removing the black box warning on hormone replacement therapy for menopause. Agency leaders said the listed risks, including breast cancer, don’t outweigh the treatment’s long-term health benefits, such as reductions in bone fractures and cognitive decline.The news has sparked interest among women who may be candidates for the therapy. Dr. Mary Jane Minkin, a clinical professor of obstetrics, gynecology and reproductive sciences at the Yale School of Medicine, joked that her patients have since been “going wild.”In an age when over-the-counter hormone tests are a dime a dozen and supplements boast of alleviating hormonal imbalances, it can be tough to know whether you may need hormonal testing and treatment or are falling prey to marketing schemes.Dr. Jan Shifren, director of the Midlife Women’s Health Center at Massachusetts General Hospital, said women experiencing perimenopause, the years leading up to their final menstrual period, are a prime target for such “meno-profiteering” or “meno-washing,” the practice of selling pseudoscience for women during menopausal transition.“I actually never use the words ‘hormone imbalance’ with my patients,” Shifren said. “There are a lot of people out there marketing very expensive hormone testing — often not covered by insurance — these very large panels of multiple hormones that essentially tell us nothing.”The U.S. endocrine testing market, which encompasses hormone tests, has flourished since the pandemic, according to Grand View Research, an international consulting and market research firm. Its market size was about $4.1 billion in 2022 and is estimated to soar at a 7.7% compound annual growth rate from 2024 to 2030, mirroring global projections.While hospitals commanded the global endocrine testing market in 2023, commercial laboratories are expected to see the fastest annual growth through 2030, projections show.In the U.S., commercial labs such as Labcorp and Quest Diagnostics offer prescription-free options ranging from a single $49 test measuring the luteinizing hormone, which helps regulate the menstrual cycle, to an in-depth hormone panel exceeding $500.Numerous telehealth companies sell similar tests, which may involve blood, urine or saliva collection, with some approaching $1,000 per panel. HealthLabs.com, for example, offers a “comprehensive female hormone panel” that measures hormones including estrogens, thyroid hormones, testosterone and human growth hormone. The panel, which also includes tests for cholesterol, folic acid and vitamin B12, has a list price of $1,598 but was on sale for $799 as of Nov. 13.“I see women in my practice all the time who have spent $600 for an online consult, they’re spending $600 or $700 every few months for a very large panel of unnecessary hormone levels,” Shifren said. “Then when they come to see me, I don’t want to look at any of those levels. I want to talk to them about what’s bothering them, what their symptoms are.”Follow the symptoms, not hormone levelsPerimenopause typically begins between the ages of 45 and 55 and can last up to a decade. Menopause marks a single point in time, 12 months after a woman’s final period, followed by postmenopause for the rest of a woman’s life.More than 1 million women in the U.S. reach menopause each year, at age 52 on average, according to the National Institute on Aging.“Half of all people on this planet will go through menopause if they’re fortunate enough to live long enough,” Shifren said. “That’s an important time of life.”Tired of Feeling Tired? Why You May Need a Cortisol Reset04:28It can also be a time when quality of life diminishes for women experiencing symptoms, which may include hot flashes and night sweats, brain fog, mood swings, weight gain, painful sex, breast tenderness, incontinence, insomnia, vaginal dryness and irregular periods.When Minkin sees a patient in her 40s or 50s with such symptoms, treatment is the goal — no hormone testing needed.“In general, I try to discourage people [from testing] as much as possible,” Minkin said. “Particularly in the perimenopausal situation, hormones fluctuate all over the place.”Not to mention, Minkin said, even a premenopausal woman’s reproductive hormones vary widely throughout her cycle.Minkin also advises patients against purchasing hormone panels on their own.“My standard example is, if I have a patient who’s 53 years old … hasn’t had a period for three months and she’s up every night, sweating and not sleeping and not feeling good, and she wants her hormone levels tested,” Minkin said. “[I’d] say to her, ‘Please, go out and buy a dress with that money. I can tell you you’re perimenopausal.’”Similarly, older women don’t often benefit from sex hormone testing, Shifren said.“There’s absolutely no reason to check estradiol [a form of estrogen] or progesterone in a postmenopausal woman,” Shifren said. “We can tell them — before they spend any money — that those levels are low.”Who would benefit from hormone testing?When it comes to perimenopausal symptoms, age matters, said Dr. Shamita Misra, a clinical professor of family and community medicine at the University of Missouri School of Medicine.Menopause occurring between the ages of 40 and 45 is considered early, while reaching the milestone younger than 40 constitutes premature menopause. Roughly 5% of women hit early menopause naturally, as opposed to the condition being induced by surgical or other medical interventions, according to the federal Office on Women’s Health.Because early or premature menopause is associated with a higher risk of conditions including heart disease and osteoporosis, a patient under 40 reporting perimenopausal symptoms may benefit from hormone testing, Misra said.“Are we suspecting premature menopause, or is there any other endocrine problem?” Misra said. “We have to be open and not just focus on perimenopause. We have to also get [the patient’s] history.”On the other hand, if you’re of normal perimenopausal age and dealing with symptoms, don’t shy away from discussing any hormonal concerns you may have with your health care provider, Misra said. Shared, informed decision-making is your safest option.“Some women don’t talk candidly about their symptoms,” Misra said.If your doctor does recommend hormone testing, keep in mind that some medications, including birth control, may affect your levels.“You would have to be off birth control for 90 days — minimum three months — before your hormones get back to being at their baseline,” Misra said. “When a person is breastfeeding, for example, when a person is on oral contraception or some hormones already, it’s impossible to check for hormone levels accurately.”Risks from unnecessary hormone testingIt’s natural to be curious about hormone levels — reproductive or otherwise — whether you’re symptomatic or not, doctors say. Some of Dr. Debra Bell’s patients have told her they need data to feel comfortable about their health, even when she doesn’t need data to treat them.“My approach is, How will this test help us in our decision-making for your situation?” said Bell, director of education at the Osher Center for Integrative Health at the University of Washington School of Medicine. “It doesn’t always help.”But just because hormone testing isn’t typically beneficial for peri- and postmenopausal women doesn’t mean it’s harmless, Bell said. Cost is one such harm.“I know people who have maxed out their credit card for these kinds of things,” Bell said.Not all over-the-counter menopause diagnostics are pricey. For instance, pharmacy chains and big-box stores sell rapid menopause test sticks hovering around $30, sometimes less.The questions then become: How accurate are the results and who’s interpreting them?“If [a patient has] done the test, then I will interpret it for them,” Bell said. “A lot of times, what the test shows is what we might already presume based on the symptoms they’re having and what’s happening with their menstrual cycle.”Another danger in self-testing is self-treating one’s perceived hormone imbalance, Bell said. Unlike prescription medications, the FDA doesn’t approve herbal and dietary supplements for safety or effectiveness before they hit store shelves.Last year’s global menopause market was nearly $18 billion, Grand View Research reports, with dietary supplements carving out a 94% share.As a practitioner of integrative medicine, Bell is hardly antisupplement. But be sure to discuss any supplements you’re considering with your doctor, she said. Even supplements marketed as natural may be toxic depending on your lifestyle, medical history and other medications you’re on.Hot flash treatments in particular have a high placebo effect rate in clinical trials, about 30%-35%, Minkin estimated. For that reason, she said she has no problem with patients who claim that home remedies such as evening primrose oil provide symptom relief.“As long as it’s something that I know is pretty safe,” Minkin said. “[If] she says it’s arsenic, I’d say, ‘Probably not a good idea.’ So I have to look at the potential toxicity of what she might be using.”Minkin is thrilled that menopause, once taboo, is not only making headlines but also being celebrated — an “estrogen festival,” she called it. However, she warned that some wellness companies are crashing the party, hoping to make money off women in midlife.“For 20 years, we could attribute nothing to menopause; it was a dirty topic,” Minkin said. “But at this point, I think we’re leaning toward saying that everything is perimenopause, because perimenopause is very amorphous.”“You can’t test for it, really.”Lindsey LeakeLindsey Leake is an award-winning health journalist and contributor to NBC News. She holds an MA in Science Writing from Johns Hopkins University, an MA in Journalism and Digital Storytelling from American University and a BA from Princeton University.
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved